Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Getz

Showing results (61-70 of 396) with videos related to

Pageof 40
Sort By:
Nature Communications|February 7, 2020
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsWei Jiao, Gurnit Atwal, Paz Polak, et al.
Nature Communications|December 8, 2022
Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsWei Jiao, Gurnit Atwal, Paz Polak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2023
Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint InhibitorsJoseph Toker, J Bryan Iorgulescu, Alexander L Ling, et al.
Nature Cancer|April 20, 2023
Inferring early genetic progression in cancers with unobtainable premalignant diseaseIgnaty Leshchiner, Edmund A Mroz, Justin Cha, et al.
Blood|March 8, 2021
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemiaIshwarya Murali, Siddha Kasar, Aishath Naeem, et al.
Nature Genetics|August 11, 2015
An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancersKin Chan, Steven A Roberts, Leszek J Klimczak, et al.
Cancer Research|August 30, 2022
High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant VulnerabilitiesWhijae Roh, Yifat Geffen, Hongui Cha, et al.
The Journal of Clinical Investigation|July 17, 2012
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancersRyan S Lee, Chip Stewart, Scott L Carter, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Single Cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
Genome Research|November 22, 2018
Quantification of somatic mutation flow across individual cell division events by lineage sequencingYehuda Brody, Robert J Kimmerling, Yosef E Maruvka, et al.
Pageof 40

Showing results (61-70 of 396) with videos related to

Sort By:
Pageof 40
Nature Communications|February 7, 2020
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsWei Jiao, Gurnit Atwal, Paz Polak, et al.
Nature Communications|December 8, 2022
Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsWei Jiao, Gurnit Atwal, Paz Polak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2023
Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint InhibitorsJoseph Toker, J Bryan Iorgulescu, Alexander L Ling, et al.
Nature Cancer|April 20, 2023
Inferring early genetic progression in cancers with unobtainable premalignant diseaseIgnaty Leshchiner, Edmund A Mroz, Justin Cha, et al.
Blood|March 8, 2021
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemiaIshwarya Murali, Siddha Kasar, Aishath Naeem, et al.
Nature Genetics|August 11, 2015
An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancersKin Chan, Steven A Roberts, Leszek J Klimczak, et al.
Cancer Research|August 30, 2022
High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant VulnerabilitiesWhijae Roh, Yifat Geffen, Hongui Cha, et al.
The Journal of Clinical Investigation|July 17, 2012
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancersRyan S Lee, Chip Stewart, Scott L Carter, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Single Cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
Genome Research|November 22, 2018
Quantification of somatic mutation flow across individual cell division events by lineage sequencingYehuda Brody, Robert J Kimmerling, Yosef E Maruvka, et al.
Pageof 40